HTG Molecular Diagnostics, Inc.
HTGMQOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$221
P/E Ratio—
52W High$0.0001
52W Low$0.0001
HTG Molecular Diagnostics, Inc. (HTGMQ) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HTGMQ · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $6.37M | $8.91M | $8.55M | $19.20M | $21.50M |
| Cost of Revenue | $4.57M | $4.09M | $3.99M | $8.91M | $5.09M |
| Gross Profit | $1.79M | $4.81M | $4.56M | $10.29M | $16.41M |
| Gross Margin %(computed) | 28.18% | 54.02% | 53.31% | 53.60% | 76.33% |
| Operating Expenses | |||||
| R&D Expenses | $6.78M | $6.09M | $6.08M | $10.57M | $12.60M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $19.86M |
| Total Operating Expenses | $22.62M | $22.64M | $24.56M | $29.25M | $32.57M |
| Operating Income | ($20.83M) | ($17.82M) | ($19.59M) | ($18.96M) | ($16.16M) |
| Operating Margin %(computed) | -327.19% | -200.11% | -229.10% | -98.73% | -75.15% |
| Interest Income | $0.09M | $0.03M | $0.25M | $0.62M | $0.72M |
| Interest Expense | $0.86M | $1.06M | $1.02M | $0.96M | $0.90M |
| Income Before Tax | ($21.58M) | ($17.12M) | ($20.86M) | ($19.29M) | ($16.45M) |
| Income Tax Expense | $0.01M | $0.02M | $0.01M | $0.00M | $0.00M |
| Net Income | ($21.59M) | ($17.15M) | ($20.87M) | ($19.30M) | ($16.45M) |
| Net Margin %(computed) | -339.20% | -192.49% | -244.13% | -100.49% | -76.52% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-24.28 | $-29.66 | $-54.12 | $-91.17 | $-107.61 |
| Wtd Avg Shares | 0.89M | 0.58M | 0.39M | 0.21M | 0.15M |
| EBITDA | ($20.14M) | ($15.36M) | ($18.48M) | ($17.08M) | ($14.08M) |
| EBITDA Margin %(computed) | -316.35% | -172.41% | -216.22% | -88.93% | -65.48% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more HTG Molecular Diagnostics, Inc. data
About HTG Molecular Diagnostics, Inc. (HTGMQ) Income Statement
HTG Molecular Diagnostics, Inc. (HTGMQ) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, HTGMQ reported revenue of $0.01B, gross profit of $0.00B (gross margin 28.18%), and net income of ($0.02B) — a net profit margin of -339.20%.
Frequently asked questions
HTGMQ · 4 questionsHTG Molecular Diagnostics, Inc. (HTGMQ) reported revenue of $0.01B for 2022, down 28.5% year-over-year.
HTGMQ revenueHTGMQ salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09